chr1-197511829-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001195215.2(DENND1B):āc.1714C>Gā(p.Leu572Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,611,256 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 32)
Exomes š: 0.000032 ( 0 hom. )
Consequence
DENND1B
NM_001195215.2 missense
NM_001195215.2 missense
Scores
1
7
4
Clinical Significance
Conservation
PhyloP100: 2.37
Genes affected
DENND1B (HGNC:28404): (DENN domain containing 1B) Clathrin (see MIM 118955)-mediated endocytosis is a major mechanism for internalization of proteins and lipids. Members of the connecdenn family, such as DENND1B, function as guanine nucleotide exchange factors (GEFs) for the early endosomal small GTPase RAB35 (MIM 604199) and bind to clathrin and clathrin adaptor protein-2 (AP2; see MIM 601024). Thus, connecdenns link RAB35 activation with the clathrin machinery (Marat and McPherson, 2010 [PubMed 20154091]).[supplied by OMIM, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DENND1B | NM_001195215.2 | c.1714C>G | p.Leu572Val | missense_variant | 22/23 | ENST00000620048.6 | NP_001182144.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DENND1B | ENST00000620048.6 | c.1714C>G | p.Leu572Val | missense_variant | 22/23 | 5 | NM_001195215.2 | ENSP00000479816.1 | ||
DENND1B | ENST00000294737.11 | n.*402C>G | non_coding_transcript_exon_variant | 19/20 | 2 | ENSP00000294737.7 | ||||
DENND1B | ENST00000294737.11 | n.*402C>G | 3_prime_UTR_variant | 19/20 | 2 | ENSP00000294737.7 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151772Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
151772
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249876Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135074
GnomAD3 exomes
AF:
AC:
6
AN:
249876
Hom.:
AF XY:
AC XY:
2
AN XY:
135074
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1459484Hom.: 0 Cov.: 33 AF XY: 0.0000386 AC XY: 28AN XY: 726054
GnomAD4 exome
AF:
AC:
47
AN:
1459484
Hom.:
Cov.:
33
AF XY:
AC XY:
28
AN XY:
726054
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151772Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74118
GnomAD4 genome
AF:
AC:
5
AN:
151772
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74118
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.1714C>G (p.L572V) alteration is located in exon 22 (coding exon 22) of the DENND1B gene. This alteration results from a C to G substitution at nucleotide position 1714, causing the leucine (L) at amino acid position 572 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
PrimateAI
Uncertain
T
Sift4G
Benign
T
Vest4
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at